430 related articles for article (PubMed ID: 24686846)
41. Germline mutations in Protection of Telomeres 1 in two families with Hodgkin lymphoma.
McMaster ML; Sun C; Landi MT; Savage SA; Rotunno M; Yang XR; Jones K; Vogt A; Hutchinson A; Zhu B; Wang M; Hicks B; Thirunavukarason A; Stewart DR; Koutros S; Goldstein AM; Chanock SJ; Caporaso NE; Tucker MA; Goldin LR; Liu Y
Br J Haematol; 2018 May; 181(3):372-377. PubMed ID: 29693246
[TBL] [Abstract][Full Text] [Related]
42. A POT1 mutation implicates defective telomere end fill-in and telomere truncations in Coats plus.
Takai H; Jenkinson E; Kabir S; Babul-Hirji R; Najm-Tehrani N; Chitayat DA; Crow YJ; de Lange T
Genes Dev; 2016 Apr; 30(7):812-26. PubMed ID: 27013236
[TBL] [Abstract][Full Text] [Related]
43. Characterization of melanoma susceptibility genes in high-risk patients from Central Italy.
Pellegrini C; Maturo MG; Martorelli C; Suppa M; Antonini A; Kostaki D; Verna L; Landi MT; Peris K; Fargnoli MC
Melanoma Res; 2017 Jun; 27(3):258-267. PubMed ID: 28146043
[TBL] [Abstract][Full Text] [Related]
44. CDKN2A and BAP1 germline mutations predispose to melanoma and mesothelioma.
Betti M; Aspesi A; Biasi A; Casalone E; Ferrante D; Ogliara P; Gironi LC; Giorgione R; Farinelli P; Grosso F; Libener R; Rosato S; Turchetti D; Maffè A; Casadio C; Ascoli V; Dianzani C; Colombo E; Piccolini E; Pavesi M; Miccoli S; Mirabelli D; Bracco C; Righi L; Boldorini R; Papotti M; Matullo G; Magnani C; Pasini B; Dianzani I
Cancer Lett; 2016 Aug; 378(2):120-30. PubMed ID: 27181379
[TBL] [Abstract][Full Text] [Related]
45. Recent emergence and extinction of the protection of telomeres 1c gene in Arabidopsis thaliana.
Kobayashi CR; Castillo-González C; Survotseva Y; Canal E; Nelson ADL; Shippen DE
Plant Cell Rep; 2019 Sep; 38(9):1081-1097. PubMed ID: 31134349
[TBL] [Abstract][Full Text] [Related]
46. Unusual suspects in hereditary melanoma: POT1, POLE, BAP1.
Maas EJ; Betz-Stablein B; Aoude LG; Soyer HP; McInerney-Leo AM
Trends Genet; 2022 Dec; 38(12):1204-1207. PubMed ID: 35811174
[TBL] [Abstract][Full Text] [Related]
47. Telomere length, TERT and shelterin complex proteins in hepatocellular carcinomas expressing "stemness"-related markers.
Kim H; Yoo JE; Cho JY; Oh BK; Yoon YS; Han HS; Lee HS; Jang JJ; Jeong SH; Kim JW; Park YN
J Hepatol; 2013 Oct; 59(4):746-52. PubMed ID: 23685049
[TBL] [Abstract][Full Text] [Related]
48. The wide spectrum of POT1 gene variants correlates with multiple cancer types.
Calvete O; Garcia-Pavia P; Domínguez F; Bougeard G; Kunze K; Braeuninger A; Teule A; Lasa A; Ramón Y Cajal T; Llort G; Fernández V; Lázaro C; Urioste M; Benitez J
Eur J Hum Genet; 2017 Nov; 25(11):1278-1281. PubMed ID: 28853721
[TBL] [Abstract][Full Text] [Related]
49. Structural insights into POT1-TPP1 interaction and POT1 C-terminal mutations in human cancer.
Chen C; Gu P; Wu J; Chen X; Niu S; Sun H; Wu L; Li N; Peng J; Shi S; Fan C; Huang M; Wong CC; Gong Q; Kumar-Sinha C; Zhang R; Pusztai L; Rai R; Chang S; Lei M
Nat Commun; 2017 Apr; 8():14929. PubMed ID: 28393832
[TBL] [Abstract][Full Text] [Related]
50. Characterization of POT1 tumor predisposition syndrome: Tumor prevalence in a clinically diverse hereditary cancer cohort.
Herrera-Mullar J; Fulk K; Brannan T; Yussuf A; Polfus L; Richardson ME; Horton C
Genet Med; 2023 Nov; 25(11):100937. PubMed ID: 37466057
[TBL] [Abstract][Full Text] [Related]
51. Dynamic peptides of human TPP1 fulfill diverse functions in telomere maintenance.
Rajavel M; Orban T; Xu M; Hernandez-Sanchez W; de la Fuente M; Palczewski K; Taylor DJ
Nucleic Acids Res; 2016 Dec; 44(21):10467-10479. PubMed ID: 27655633
[TBL] [Abstract][Full Text] [Related]
52. POT1 mutations cause differential effects on telomere length leading to opposing disease phenotypes.
Zade NH; Khattar E
J Cell Physiol; 2023 Jun; 238(6):1237-1255. PubMed ID: 37183325
[TBL] [Abstract][Full Text] [Related]
53. Genetic counselling and high-penetrance susceptibility gene analysis reveal the novel CDKN2A p.D84V (c.251A>T) mutation in melanoma-prone families from Italy.
Borroni RG; Manganoni AM; Grassi S; Grasso M; Diegoli M; Giorgianni C; Favalli V; Pavoni L; Cespa M; Arbustini E
Melanoma Res; 2017 Apr; 27(2):97-103. PubMed ID: 28060055
[TBL] [Abstract][Full Text] [Related]
54. TSPYL5 Depletion Induces Specific Death of ALT Cells through USP7-Dependent Proteasomal Degradation of POT1.
Episkopou H; Diman A; Claude E; Viceconte N; Decottignies A
Mol Cell; 2019 Aug; 75(3):469-482.e6. PubMed ID: 31278054
[TBL] [Abstract][Full Text] [Related]
55. EDNRB gene variants and melanoma risk in two southern European populations.
Spica T; Fargnoli MC; Hetet G; Bertrand G; Formicone F; Descamps V; Wolkenstein P; Dupin N; Lebbe C; Basset-Seguin N; Saiag P; Cambien F; Grandchamp B; Peris K; Soufir N
Clin Exp Dermatol; 2011 Oct; 36(7):782-7. PubMed ID: 21507037
[TBL] [Abstract][Full Text] [Related]
56. A population-based analysis of germline BAP1 mutations in melanoma.
O'Shea SJ; Robles-Espinoza CD; McLellan L; Harrigan J; Jacq X; Hewinson J; Iyer V; Merchant W; Elliott F; Harland M; Bishop DT; Newton-Bishop JA; Adams DJ
Hum Mol Genet; 2017 Feb; 26(4):717-728. PubMed ID: 28062663
[TBL] [Abstract][Full Text] [Related]
57. A Germline Mutation in the
Srivastava A; Miao B; Skopelitou D; Kumar V; Kumar A; Paramasivam N; Bonora E; Hemminki K; Försti A; Bandapalli OR
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32492864
[TBL] [Abstract][Full Text] [Related]
58. Functional diversity of human protection of telomeres 1 isoforms in telomere protection and cellular senescence.
Yang Q; Zhang R; Horikawa I; Fujita K; Afshar Y; Kokko A; Laiho P; Aaltonen LA; Harris CC
Cancer Res; 2007 Dec; 67(24):11677-86. PubMed ID: 18089797
[TBL] [Abstract][Full Text] [Related]
59. Report of a novel OCA2 gene mutation and an investigation of OCA2 variants on melanoma risk in a familial melanoma pedigree.
Hawkes JE; Cassidy PB; Manga P; Boissy RE; Goldgar D; Cannon-Albright L; Florell SR; Leachman SA
J Dermatol Sci; 2013 Jan; 69(1):30-7. PubMed ID: 23103111
[TBL] [Abstract][Full Text] [Related]
60. Human Pot1 (protection of telomeres) protein: cytolocalization, gene structure, and alternative splicing.
Baumann P; Podell E; Cech TR
Mol Cell Biol; 2002 Nov; 22(22):8079-87. PubMed ID: 12391173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
